<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:dc="http://purl.org/dc/elements/1.1/">
<channel>
<title>心血管高分期刊</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;ff=20241016001328&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome&amp;fc=20230708114047
    <description>心血管高分期刊: Latest results from PubMed</description>
<atom:link href="https://pubmed.ncbi.nlm.nih.gov/rss-feed/?feed_id=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;v=2.18.0.post9+e462414&amp;ff=20241016001328&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;utm_campaign=pubmed-2&amp;utm_medium=rss&amp;utm_source=Chrome&amp;fc=20230708114047" rel="self"></atom:link>
<docs>http://www.rssboard.org/rss-specification</docs>
<generator>PubMed RSS feeds (2.18.0.post9+e462414)</generator>
<language>en</language>
<lastbuilddate>Wed, 16 Oct 2024 04:13:29 +0000</lastbuilddate>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<ttl>120</ttl>
<item>
<title>Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405409/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: Biphasic DT-CMR identifies microstructural alterations in both diastole and systole after STEMI, enabling detection of MI presence and location as well as predicting adverse LV remodelling. DT-CMR has potential to provide a single contrast-free modality for MI detection and prognostication of patients after acute STEMI.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae667. doi: 10.1093/eurheartj/ehae667. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Microstructural disturbances underlie dysfunctional contraction and adverse left ventricular (LV) remodelling after ST-elevation myocardial infarction (STEMI). Biphasic diffusion tensor cardiovascular magnetic resonance (DT-CMR) quantifies dynamic reorientation of sheetlets (E2A) from diastole to systole during myocardial thickening, and markers of tissue integrity [mean diffusivity (MD) and fractional anisotropy (FA)]. This study investigated whether microstructural alterations identified by biphasic DT-CMR: (i) enable contrast-free detection of acute myocardial infarction (MI); (ii) associate with severity of myocardial injury and contractile dysfunction; and (iii) predict adverse LV remodelling.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: Biphasic DT-CMR was acquired 4 days (n = 70) and 4 months (n = 66) after reperfused STEMI and in healthy volunteers (HVOLs) (n = 22). Adverse LV remodelling was defined as an increase in LV end-diastolic volume ≥ 20% at 4 months. MD and FA maps were compared with late gadolinium enhancement images.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Widespread microstructural disturbances were detected post-STEMI. In the acute MI zone, diastolic E2A was raised and systolic E2A reduced, resulting in reduced E2A mobility (all P &lt; .001 vs. adjacent and remote zones and HVOLs). Acute global E2A mobility was the only independent predictor of adverse LV remodelling (odds ratio .77; 95% confidence interval .63-.94; P = .010). MD and FA maps had excellent sensitivity and specificity (all >; 90%) and interobserver agreement for detecting MI presence and location.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: Biphasic DT-CMR identifies microstructural alterations in both diastole and systole after STEMI, enabling detection of MI presence and location as well as predicting adverse LV remodelling. DT-CMR has potential to provide a single contrast-free modality for MI detection and prognostication of patients after acute STEMI.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405409/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405409</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae667>10.1093/eurheartj/ehae667</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405409</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Ramyah Rajakulasingam</dc:creator>
<dc:creator>Pedro F Ferreira</dc:creator>
<dc:creator>Andrew D Scott</dc:creator>
<dc:creator>Zohya Khalique</dc:creator>
<dc:creator>Alessia Azzu</dc:creator>
<dc:creator>Maria Molto</dc:creator>
<dc:creator>Miriam Conway</dc:creator>
<dc:creator>Emanuela Falaschetti</dc:creator>
<dc:creator>Kevin Cheng</dc:creator>
<dc:creator>Daniel J Hammersley</dc:creator>
<dc:creator>Emily-Jane Cantor</dc:creator>
<dc:creator>Alexander Tindale</dc:creator>
<dc:creator>Catherine J Beattie</dc:creator>
<dc:creator>Arjun Banerjee</dc:creator>
<dc:creator>Ricardo Wage</dc:creator>
<dc:creator>Raj K Soundarajan</dc:creator>
<dc:creator>Miles Dalby</dc:creator>
<dc:creator>Sonia Nielles-Vallespin</dc:creator>
<dc:creator>Dudley J Pennell</dc:creator>
<dc:creator>Ranil de Silva</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Characterization of dynamic changes in cardiac microstructure after reperfused ST-elevation myocardial infarction by biphasic diffusion tensor cardiovascular magnetic resonance</dc:title>
<dc:identifier>pmid:39405409</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae667</dc:identifier>
</item>
<item>
<title>Seeing music's effect on the heart</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405174/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae436. doi: 10.1093/eurheartj/ehae436. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405174/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405174</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae436>10.1093/eurheartj/ehae436</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405174</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Elaine Chew</dc:creator>
<dc:creator>Lawrence Fyfe</dc:creator>
<dc:creator>Charles Picasso</dc:creator>
<dc:creator>Pier Lambiase</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Seeing music's effect on the heart</dc:title>
<dc:identifier>pmid:39405174</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae436</dc:identifier>
</item>
<item>
<title>Concerns about the follow-up time and the evaluation of frailty index: potential limitations and current solutions</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405165/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae678. doi: 10.1093/eurheartj/ehae678. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405165/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405165</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae678>10.1093/eurheartj/ehae678</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405165</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Di He</dc:creator>
<dc:creator>Dan Zhou</dc:creator>
<dc:creator>Yimin Zhu</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Concerns about the follow-up time and the evaluation of frailty index: potential limitations and current solutions</dc:title>
<dc:identifier>pmid:39405165</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae678</dc:identifier>
</item>
<item>
<title>An unusual aortic coarctation located in Zone 2 causes left subclavian steal syndrome</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405164/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae681. doi: 10.1093/eurheartj/ehae681. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405164/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405164</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae681>10.1093/eurheartj/ehae681</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405164</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jiehua Li</dc:creator>
<dc:creator>Hao He</dc:creator>
<dc:creator>Chang Shu</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>An unusual aortic coarctation located in Zone 2 causes left subclavian steal syndrome</dc:title>
<dc:identifier>pmid:39405164</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae681</dc:identifier>
</item>
<item>
<title>Correction to: An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405160/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae394. doi: 10.1093/eurheartj/ehae394. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405160/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405160</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae394>10.1093/eurheartj/ehae394</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405160</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Correction to: An autoantibody identifies arrhythmogenic right ventricular cardiomyopathy and participates in its pathogenesis</dc:title>
<dc:identifier>pmid:39405160</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae394</dc:identifier>
</item>
<item>
<title>Concerns on 'Changes in frailty and incident cardiovascular disease in three prospective cohorts'</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405053/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae677. doi: 10.1093/eurheartj/ehae677. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405053/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405053</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae677>10.1093/eurheartj/ehae677</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405053</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Guo-Sheng Li</dc:creator>
<dc:creator>Hua-Fu Zhou</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Concerns on 'Changes in frailty and incident cardiovascular disease in three prospective cohorts'</dc:title>
<dc:identifier>pmid:39405053</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae677</dc:identifier>
</item>
<item>
<title>The win ratio in cardiology trials: lessons learnt, new developments, and wise future use</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39405050/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>The win ratio method for analysing a composite clinical hierarchy of outcomes is growing in popularity especially in cardiovascular trials. This article gives a perspective on its use so far and the issues derived from that experience. Specifically, it focuses on the limitations of a conventional composite outcome; how does the win ratio work, what does it mean, and how to display its findings; guidance on choosing an appropriate clinical hierarchy of outcomes including clinical events,...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae647. doi: 10.1093/eurheartj/ehae647. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">The win ratio method for analysing a composite clinical hierarchy of outcomes is growing in popularity especially in cardiovascular trials. This article gives a perspective on its use so far and the issues derived from that experience. Specifically, it focuses on the limitations of a conventional composite outcome; how does the win ratio work, what does it mean, and how to display its findings; guidance on choosing an appropriate clinical hierarchy of outcomes including clinical events, quantitative outcomes, and other options; the additional value of the win difference as a measure of absolute benefit: extension to stratified win ratio, subgroup analysis, matched win ratio, and covariate adjustment; determining trial size for a win ratio outcome; specific insights such as adaptive designs, use of repeat events, and use of margins and time averages for quantitative outcomes; a critique of potential misuses; availability of statistical software; and a statistical appendix on the methodological details. Throughout, each principle is illustrated by examples from specific cardiology trials. The article concludes with a set of recommendations for future use of the win ratio.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39405050/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39405050</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae647>10.1093/eurheartj/ehae647</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39405050</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Stuart J Pocock</dc:creator>
<dc:creator>John Gregson</dc:creator>
<dc:creator>Timothy J Collier</dc:creator>
<dc:creator>Joao Pedro Ferreira</dc:creator>
<dc:creator>Gregg W Stone</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The win ratio in cardiology trials: lessons learnt, new developments, and wise future use</dc:title>
<dc:identifier>pmid:39405050</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae647</dc:identifier>
</item>
<item>
<title>The Aesculapius project in Africa</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39403782/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae500. doi: 10.1093/eurheartj/ehae500. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39403782/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39403782</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae500>10.1093/eurheartj/ehae500</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39403782</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Roberto Ferrari</dc:creator>
<dc:creator>Alessandro Frigiola</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The Aesculapius project in Africa</dc:title>
<dc:identifier>pmid:39403782</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae500</dc:identifier>
</item>
<item>
<title>Tackling the obesity epidemic: a Brazilian perspective</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39403765/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae494. doi: 10.1093/eurheartj/ehae494. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39403765/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39403765</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae494>10.1093/eurheartj/ehae494</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39403765</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jose Francisco Kerr Saraiva</dc:creator>
<dc:creator>Elaine Dos Reis Coutinho</dc:creator>
<dc:creator>Sergio Emanuel Kaiser</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Tackling the obesity epidemic: a Brazilian perspective</dc:title>
<dc:identifier>pmid:39403765</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae494</dc:identifier>
</item>
<item>
<title>The Global Working Group on Cardiopulmonary Risk in chronic obstructive pulmonary disease</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39402981/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 15:ehae628. doi: 10.1093/eurheartj/ehae628. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39402981/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39402981</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae628>10.1093/eurheartj/ehae628</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39402981</guid>
<pubDate>Tue, 15 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Chris P Gale</dc:creator>
<dc:creator>David D Berg</dc:creator>
<dc:creator>Mohit Bhutani</dc:creator>
<dc:date>2024-10-15</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>The Global Working Group on Cardiopulmonary Risk in chronic obstructive pulmonary disease</dc:title>
<dc:identifier>pmid:39402981</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae628</dc:identifier>
</item>
<item>
<title>Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401282/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):1220-1222. doi: 10.1161/CIRCULATIONAHA.124.069759. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401282/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401282</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069759>10.1161/CIRCULATIONAHA.124.069759</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401282</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Christian Sohns</dc:creator>
<dc:creator>Philipp Sommer</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Patients With Advanced Heart Failure and Atrial Fibrillation Deserve an Attempt at Catheter Ablation as First-Line Therapy</dc:title>
<dc:identifier>pmid:39401282</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069759</dc:identifier>
</item>
<item>
<title>Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401281/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):1217-1219. doi: 10.1161/CIRCULATIONAHA.124.070087. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401281/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401281</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070087>10.1161/CIRCULATIONAHA.124.070087</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401281</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Peter Libby</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Pathogenesis of Atherothrombotic Events: From Lumen to Lesion and Beyond</dc:title>
<dc:identifier>pmid:39401281</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070087</dc:identifier>
</item>
<item>
<title>Response by Hoedemakers et al to Letter Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401280/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):e278-e279. doi: 10.1161/CIRCULATIONAHA.124.071022. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401280/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401280</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.071022>10.1161/CIRCULATIONAHA.124.071022</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401280</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Sarah Hoedemakers</dc:creator>
<dc:creator>Bernard Cosyns</dc:creator>
<dc:creator>Steven Droogmans</dc:creator>
<dc:creator>Frederik H Verbrugge</dc:creator>
<dc:creator>Lieven Herbots</dc:creator>
<dc:creator>Jan Verwerft</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Response by Hoedemakers et al to Letter Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis"</dc:title>
<dc:identifier>pmid:39401280</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.071022</dc:identifier>
</item>
<item>
<title>Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401279/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, as more weight loss is achieved, there is concern for potential adverse effects on muscle quantity, composition, and function. This primer aims to address whether muscle-related changes associated with weight loss treatments such as GLP-1 RAs may be maladaptive (ie, adversely affecting muscle health...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):1288-1298. doi: 10.1161/CIRCULATIONAHA.124.067676. Epub 2024 Oct 14.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and combination therapies is approaching magnitudes achieved with surgery. However, as more weight loss is achieved, there is concern for potential adverse effects on muscle quantity, composition, and function. This primer aims to address whether muscle-related changes associated with weight loss treatments such as GLP-1 RAs may be maladaptive (ie, adversely affecting muscle health or function), adaptive (ie, a physiologic response to weight loss maintaining or minimally affecting muscle health or function), or perhaps an enhanced response to weight loss (ie, improved muscle health or function after treatment). Based on contemporary evidence with the addition of studies using magnetic resonance imaging, skeletal muscle changes with GLP-1 RA treatments appear to be adaptive: changes in muscle volume z-score indicate a change in muscle volume that is commensurate with what is expected given aging, disease status, and weight loss achieved, and the improvement in insulin sensitivity and muscle fat infiltration likely contributes to an adaptive process with improved muscle quality, lowering the probability for loss in strength and function. Nevertheless, factors such as older age and prefrailty may influence the selection of appropriate candidates for these therapies because of risk for sarcopenia. Several pharmacologic treatments to maintain or improve muscle mass designed in combination with GLP-1-based therapies are under development. For future development of GLP-1-based therapies (and other therapies) designed for weight loss, as well as for patient-centered treatment optimization, the introduction of more objective and comprehensive ways of assessing muscle health (including accurate and meaningful assessments of muscle quantity, composition, function, mobility, and strength) is important for the substantial numbers of patients who will likely be taking these medications well into the future.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401279/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401279</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.067676>10.1161/CIRCULATIONAHA.124.067676</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401279</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jennifer Linge</dc:creator>
<dc:creator>Andreas L Birkenfeld</dc:creator>
<dc:creator>Ian J Neeland</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?</dc:title>
<dc:identifier>pmid:39401279</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.067676</dc:identifier>
</item>
<item>
<title>Sustained but Decoyed Activation of the JAK1-STAT Pathway by Aberrant Protein Aggregation Exacerbates Proteotoxicity</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401278/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):1302-1305. doi: 10.1161/CIRCULATIONAHA.124.070067. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401278/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401278</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070067>10.1161/CIRCULATIONAHA.124.070067</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401278</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Mingqi Cai</dc:creator>
<dc:creator>Bo Pan</dc:creator>
<dc:creator>Peng Xiao</dc:creator>
<dc:creator>Mark Bouska</dc:creator>
<dc:creator>Megan T Lewno</dc:creator>
<dc:creator>Yu Xing</dc:creator>
<dc:creator>Erliang Zeng</dc:creator>
<dc:creator>Huiyun Liang</dc:creator>
<dc:creator>Faqian Li</dc:creator>
<dc:creator>Xiang Gao</dc:creator>
<dc:creator>Xuejun Wang</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Sustained but Decoyed Activation of the JAK1-STAT Pathway by Aberrant Protein Aggregation Exacerbates Proteotoxicity</dc:title>
<dc:identifier>pmid:39401278</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070067</dc:identifier>
</item>
<item>
<title>Optical Spectroscopic Detection and Typing of Cardiac Amyloidosis</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401277/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):1299-1301. doi: 10.1161/CIRCULATIONAHA.124.069554. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401277/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401277</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.069554>10.1161/CIRCULATIONAHA.124.069554</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401277</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Sudipta S Mukherjee</dc:creator>
<dc:creator>Joseph J Maleszewski</dc:creator>
<dc:creator>Daniel Luthringer</dc:creator>
<dc:creator>Matthew P Confer</dc:creator>
<dc:creator>Anirudh Mittal</dc:creator>
<dc:creator>Surendra Dasari</dc:creator>
<dc:creator>Ellen D McPhail</dc:creator>
<dc:creator>Suraj Kapa</dc:creator>
<dc:creator>Thenkurussi Kesavadas</dc:creator>
<dc:creator>Andre Kajdacsy-Balla</dc:creator>
<dc:creator>Evan Kransdorf</dc:creator>
<dc:creator>Jai Raman</dc:creator>
<dc:creator>Rohit Bhargava</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Optical Spectroscopic Detection and Typing of Cardiac Amyloidosis</dc:title>
<dc:identifier>pmid:39401277</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.069554</dc:identifier>
</item>
<item>
<title>Letter by Jha Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis"</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39401276/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;"><b>Circulation</b>. 2024 Oct 15;150(16):e276-e277. doi: 10.1161/CIRCULATIONAHA.124.070147. Epub 2024 Oct 14.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39401276/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39401276</a> | DOI:<a href=https://doi.org/10.1161/CIRCULATIONAHA.124.070147>10.1161/CIRCULATIONAHA.124.070147</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39401276</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Ajay Kumar Jha</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>Circulation</dc:source>
<dc:title>Letter by Jha Regarding Article, "mPAP/CO Slope and Oxygen Uptake Add Prognostic Value in Aortic Stenosis"</dc:title>
<dc:identifier>pmid:39401276</dc:identifier>
<dc:identifier>doi:10.1161/CIRCULATIONAHA.124.070147</dc:identifier>
</item>
<item>
<title>Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39400274/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 14;45(39):4141-4144. doi: 10.1093/eurheartj/ehae689.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39400274/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39400274</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae689>10.1093/eurheartj/ehae689</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39400274</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Filippo Crea</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Focus on ischaemic heart disease: secondary prevention, cardiogenic shock, and novel therapeutic targets</dc:title>
<dc:identifier>pmid:39400274</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae689</dc:identifier>
</item>
<item>
<title>Plasma proteome and incident myocardial infarction: sex-specific differences</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39397782/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>CONCLUSIONS: This study identified both new and confirmed previously established associations between circulating proteins and incident MI and, for the first time, suggested sex-specific patterns in multiple protein-MI associations.</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 14:ehae658. doi: 10.1093/eurheartj/ehae658. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">BACKGROUND AND AIMS: Few population-based cohort studies, including both men and women, have explored circulating proteins associated with incident myocardial infarction (MI). This study investigated the relationships between circulating cardiometabolic-related proteins and MI risk using cohort-based and Mendelian randomization (MR) analyses and explored potential sex-specific differences.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">METHODS: The discovery cohort included 11 751 Swedish adults (55-93 years). Data on 259 proteins assessed with Olink proximity extension assays, biochemical, and questionnaire-based information were used. Participants were followed up for incident MI and death over 8 years through linkage to Swedish registers. Replication analyses were conducted on the UK Biobank sample (n = 51 613). In MR analyses, index cis-genetic variants strongly related to the proteins were used as instrumental variables. Genetic association summary statistic data for MI were obtained from the CARDIoGRAMplusC4D consortium and FinnGen.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">RESULTS: Forty-five proteins were associated with incident MI in discovery and replication samples following adjustment for potential confounders and multiple testing. In the secondary analysis, 13 of the protein associations were sex-specific, with most associations identified among women. In MR analysis, genetically predicted higher levels of renin, follistatin, and retinoic acid receptor responder protein 2 were linked to an increased risk of MI. Tissue factor pathway inhibitor, tumor necrosis factor receptors 1 and 2, placenta growth factor had an inverse association with MI.</p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">CONCLUSIONS: This study identified both new and confirmed previously established associations between circulating proteins and incident MI and, for the first time, suggested sex-specific patterns in multiple protein-MI associations.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39397782/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39397782</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae658>10.1093/eurheartj/ehae658</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39397782</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Olga E Titova</dc:creator>
<dc:creator>Shuai Yuan</dc:creator>
<dc:creator>Liisa Byberg</dc:creator>
<dc:creator>John A Baron</dc:creator>
<dc:creator>Lars Lind</dc:creator>
<dc:creator>Karl Michaëlsson</dc:creator>
<dc:creator>Susanna C Larsson</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Plasma proteome and incident myocardial infarction: sex-specific differences</dc:title>
<dc:identifier>pmid:39397782</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae658</dc:identifier>
</item>
<item>
<title>Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39397778/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>No abstract</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 14:ehae657. doi: 10.1093/eurheartj/ehae657. Online ahead of print.</p><p><b>NO ABSTRACT</b></p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39397778/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39397778</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae657>10.1093/eurheartj/ehae657</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39397778</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Anna K Barton</dc:creator>
<dc:creator>Emily S Lau</dc:creator>
<dc:creator>Martha Gulati</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Steps towards curing Yentl syndrome: appraising sex differences in circulating proteins and incident myocardial infarction</dc:title>
<dc:identifier>pmid:39397778</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae657</dc:identifier>
</item>
<item>
<title>Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing</title>
<link/>https://pubmed.ncbi.nlm.nih.gov/39397777/?utm_source=Chrome&amp;utm_medium=rss&amp;utm_campaign=pubmed-2&amp;utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&amp;fc=20230708114047&amp;ff=20241016001328&amp;v=2.18.0.post9+e462414
      <description>Despite key advances in catheter-based treatments, the management of persistent atrial fibrillation (AF) remains a therapeutic challenge in a significant subset of patients. While success rates have improved with repeat AF ablation procedures and the concurrent use of antiarrhythmic drugs, the likelihood of maintaining sinus rhythm during long-term follow-up is still limited. Atrioventricular node ablation (AVNA) has returned as a valuable treatment option given the recent developments in...</description>
<content:encoded><![CDATA[<div><p style="color: #4aa564;">Eur Heart J. 2024 Oct 14:ehae656. doi: 10.1093/eurheartj/ehae656. Online ahead of print.</p><p><b>ABSTRACT</b></p><p xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:p1="http://pubmed.gov/pub-one">Despite key advances in catheter-based treatments, the management of persistent atrial fibrillation (AF) remains a therapeutic challenge in a significant subset of patients. While success rates have improved with repeat AF ablation procedures and the concurrent use of antiarrhythmic drugs, the likelihood of maintaining sinus rhythm during long-term follow-up is still limited. Atrioventricular node ablation (AVNA) has returned as a valuable treatment option given the recent developments in cardiac pacing. With the advent of conduction system pacing, AVNA has seen a revival where pacing-induced cardiomyopathy after AVNA is felt to be overcome. This review will discuss the role of permanent pacemaker implantation and AVNA for AF management in this new era of conduction system pacing. Specifically, this review will discuss the haemodynamic consequences of AF and the mechanisms through which 'pace-and-ablate therapy' enhances outcomes, analyse historical and more recent literature across various pacing methods, and work to identify patient groups that may benefit from earlier implementation of this approach.</p><p style="color: lightgray">PMID:<a href="https://pubmed.ncbi.nlm.nih.gov/39397777/?utm_source=Chrome&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1vUePJ4Z_tESAAXKwJxBoGOTaabXd6U-NVu8003KrCpq8yLQC-&fc=20230708114047&ff=20241016001328&v=2.18.0.post9+e462414">39397777</a> | DOI:<a href=https://doi.org/10.1093/eurheartj/ehae656>10.1093/eurheartj/ehae656</a></p></div>]]></content:encoded>
<guid ispermalink="false">pubmed:39397777</guid>
<pubDate>Mon, 14 Oct 2024 06:00:00 -0400</pubDate>
<dc:creator>Jacqueline Joza</dc:creator>
<dc:creator>Haran Burri</dc:creator>
<dc:creator>Jason G Andrade</dc:creator>
<dc:creator>Dominik Linz</dc:creator>
<dc:creator>Kenneth A Ellenbogen</dc:creator>
<dc:creator>Kevin Vernooy</dc:creator>
<dc:date>2024-10-14</dc:date>
<dc:source>European heart journal</dc:source>
<dc:title>Atrioventricular node ablation for atrial fibrillation in the era of conduction system pacing</dc:title>
<dc:identifier>pmid:39397777</dc:identifier>
<dc:identifier>doi:10.1093/eurheartj/ehae656</dc:identifier>
</item>





























</channel>
</rss>